Clinical Trials Browser

Completed × INDUSTRY × Eflornithine × Clear all

NCT01483144 2021-06-08

Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)

Phase 3 Completed

171 enrolled 13 charts

Gastrointestinal

Adenomatous Polyposis Coli